CohBar, Inc. CohBar, Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisors
  • Science
    • Overview
    • Platform Technology
    • Pipeline
  • News & Media
    • Press Releases
    • Publications
    • Events
    • Media
    • Newsroom
  • Investors
    • Overview
    • News / Events
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • Contact
  • Careers
  • Search

Press Releases

News & Media

News & Media

  • Press Releases
  • Publications
  • Events
  • Media
  • Newsroom

CohBar Announces Key Opinion Leader Conference Call and Webcast

Apr 23, 2019

CohBar Announces the Appointment of David Greenwood to its Board of Directors

Apr 22, 2019

CohBar Reports Fourth Quarter 2018 Financial Results and Provides Business Update

Mar 18, 2019

CohBar to Announce 2018 Fourth Quarter Financial Results and Host Conference Call on March 18, 2019

Mar 4, 2019

CohBar Announces the Appointment of Dr. Phyllis Gardner to its Board of Directors

Feb 11, 2019

CohBar Appoints Philippe P. Calais, Pharm.D., Ph.D. as Interim Chief Executive Officer

Dec 10, 2018

CohBar Founder Dr. Nir Barzilai Awarded the 2018 Fondation IPSEN Longevity Prize

Nov 26, 2018

CohBar Reports Third Quarter 2018 Financial Results and Provides Business Update

Nov 14, 2018

CohBar Co-Founder and Scientific Advisor Dr. David Sinclair Named as one of TIME Magazine’s Health Care 50

Nov 8, 2018

CohBar Provides Update on CB4211 Clinical Trial

Nov 5, 2018
    • 1...
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • 11
    • ...14
    © 2021 CohBar, Inc. All Rights Reserved.
    Privacy Policy Terms of Use Sitemap